APA (7th ed.) Citation

Cao, L., Dai, C., Qin, R., Guo, Y., & Liu, J. (2019). (3R)-5,6,7-trihydroxy-3-isopropyl-3-methylisochroman-1-one enhanced the therapeutic efficacy of anti-PD1 antibody through inhibiting PI3Kδ/γ. Immunopharmacology & Immunotoxicology, 41(6), 599. https://doi.org/10.1080/08923973.2019.1678634

Chicago Style (17th ed.) Citation

Cao, Lu, ChunMei Dai, Rui Qin, YaHua Guo, and JunBao Liu. "(3R)-5,6,7-trihydroxy-3-isopropyl-3-methylisochroman-1-one Enhanced the Therapeutic Efficacy of Anti-PD1 Antibody Through Inhibiting PI3Kδ/γ." Immunopharmacology & Immunotoxicology 41, no. 6 (2019): 599. https://doi.org/10.1080/08923973.2019.1678634.

MLA (9th ed.) Citation

Cao, Lu, et al. "(3R)-5,6,7-trihydroxy-3-isopropyl-3-methylisochroman-1-one Enhanced the Therapeutic Efficacy of Anti-PD1 Antibody Through Inhibiting PI3Kδ/γ." Immunopharmacology & Immunotoxicology, vol. 41, no. 6, 2019, p. 599, https://doi.org/10.1080/08923973.2019.1678634.